Literature DB >> 25512229

Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.

Yacine Abed1, Andrés Pizzorno1, Xavier Bouhy1, Guy Boivin2.   

Abstract

Permissive neuraminidase (NA) substitutions such as R222Q, V234M and D344N have facilitated the emergence and worldwide spread of oseltamivir-resistant influenza A/Brisbane/59/2007 (H1N1)-H275Y viruses. However, the potential contribution of genetic changes in other viral segments on viral fitness remains poorly investigated. A series of recombinant A(H1N1)pdm09 and A/WSN/33 7:1 reassortants containing the wild-type (WT) A/Brisbane/59/2007 NA gene or its single (H275Y) and double (H275Y/Q222R, H275Y/M234V and H275Y/N344D) variants were generated and their replicative properties were assessed in vitro. The Q222R reversion substitution significantly reduced viral titers when evaluated in both A(H1N1)pdm09 and A/WSN/33 backgrounds. The permissive role of the R222Q was further confirmed using A/WSN/33 7:1 reassortants containing the NA gene of the oseltamivir-susceptible or oseltamivir-resistant influenza A/Mississippi/03/2001 strains. Therefore, NA permissive substitutions play a dominant role for improving viral replication of oseltamivir-resistant A (H1N1)-H275Y viruses in vitro.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fitness; H1N1; Influenza; Neuraminidase; Oseltamivir; Resistance

Mesh:

Substances:

Year:  2014        PMID: 25512229     DOI: 10.1016/j.antiviral.2014.12.006

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  5 in total

1.  An activity-integrated strategy of the identification, screening and determination of potential neuraminidase inhibitors from Radix Scutellariae.

Authors:  Wei Liu; Huilin Wang; Bo Zhu; Chengqian Yin; Shuyang Chen; Jin Li; Xie-An Yu; John Teye Azietaku; Mingrui An; Xiu-Mei Gao; Yan-Xu Chang
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

Review 2.  Drug resistance in influenza A virus: the epidemiology and management.

Authors:  Mazhar Hussain; Henry D Galvin; Tatt Y Haw; Ashley N Nutsford; Matloob Husain
Journal:  Infect Drug Resist       Date:  2017-04-20       Impact factor: 4.003

3.  Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016.

Authors:  Karoline Bragstad; Olav Hungnes; Irene Litleskare; Hans Christian Nyrerød; Dagny H Dorenberg; Siri H Hauge
Journal:  Influenza Other Respir Viruses       Date:  2019-03-04       Impact factor: 4.380

4.  Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.

Authors:  Rubaiyea Farrukee; Vithiagaran Gunalan; Sebastian Maurer-Stroh; Patrick C Reading; Aeron C Hurt
Journal:  J Virol       Date:  2022-07-14       Impact factor: 6.549

Review 5.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Authors:  Aeron C Hurt; Terry G Besselaar; Rod S Daniels; Burcu Ermetal; Alicia Fry; Larisa Gubareva; Weijuan Huang; Angie Lackenby; Raphael T C Lee; Janice Lo; Sebastian Maurer-Stroh; Ha T Nguyen; Dmitriy Pereyaslov; Helena Rebelo-de-Andrade; Marilda M Siqueira; Emi Takashita; Masato Tashiro; Danielle Tilmanis; Dayan Wang; Wenqing Zhang; Adam Meijer
Journal:  Antiviral Res       Date:  2016-06-03       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.